Preterm babies treated with steroids - a follow-up study in teenagers
This research was completed on 30 April 2003
|Project Leader||Dr R A K Jones, MD, FRCPCH and Dr P Brocklehurst, MBChB, MRCOG, MSc(Epid).|
|Location||Department of Paediatrics, Wexham Park Hospital, Slough in conjunction with the National Perinatal Epidemiology Unit, Radcliffe Infirmary, Oxford.|
|Grant awarded||30 November 1999|
|Start date||8 January 2001|
|End date||30 April 2003|
We do not provide medical advice. If you would like more information about a condition or would like to talk to someone about your health, contact NHS Choices or speak to your GP. Please see our useful links page for some links to health information, organisations we are working with and other useful organisations. We hope you will find these useful. We are not responsible for the content of any of these sites.
A quarter of very low birthweight babies needing assisted ventilation may develop chronic lung disease, requiring prolonged oxygen therapy in hospital, or even at home. Poor growth and lung function, and adverse developmental outcomes are common. In 1986, Action Research funded an international trial showing that babies treated with corticosteroids came off ventilators earlier. With short term health benefits, steroids became widely used. When any new treatment enters use (particularly in vulnerable preterm babies) it is essential to do long-term follow-up to be sure there are no unexpected adverse outcomes. So children are now being traced at age 11-14 for a full assessment of their lung function, growth and intellectual outcome.